Non-Hodgkin Lymphoma

One night, I had a dream that I played chess with Death and well, I won.

The day I found out I had cancer, my wife and I thought I would just be going in for a scan.

The novel CAR-T cell therapy, HR001, showed promise in a recent trial of patients with relapsed or refractory non-Hodgkin lymphoma.

Even though cancer made its rounds through my family and myself, nature has brought a lot of healing.

When I wore my street clothes in the hospital instead of a gown, I felt more like a person than a patient with cancer.

For patients with cancer, having a PICC or port can be convenient, but I got it removed the moment I was allowed to.

Writing poetry was something that got me through cancer and helped heal my soul.

From the Duchess of York receiving a skin cancer diagnosis to Selena Gomez contacting a fan with stage 4 disease, here’s what is happening in the oncology space this week.

The Food and Drug Administration is requesting that CAR-T cell therapies now come with a Boxed Warning about secondary malignancies that have been reported in patients who undergo these treatments.

I spent a week during last Christmas in the oncology ward of a sprawling university hospital in the Midwest.

My life in poems - check it out!

It’s been more than half a year since I rang the bell at the hospital signaling that I was free of non-Hodgkins Lymphoma.

Some topics are difficult to talk about. This is one of them.

While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results.

Patients with primary central nervous system lymphoma aged 70 and older may be eligible for Imbruvica as maintenance treatment.

Beginning in the long, cold winter of 2022, I began a series of hospitalizations to treat my stage 2 non-specific non-Hodgkin Lymphoma. For the next six months, I would spend a week in the hospital every single month.

One side effect of chemotherapy that no one warned me about was frequent urination.

The Food and Drug Administration accepted a supplemental New Drug Application for Brukinsa plus Gazyva to treat patients with relapsed or refractory follicular lymphoma.

I will continue to say that I am a “survivor,” and that is the best title I could ever receive.

From YouTuber Grace Helbig announcing her cancer diagnosis to the NFL’s Foster Moreau being in full remission, here’s what’s happening in the oncology space this week.

After chemo treatment, my nails were like tree trunks — showing ages and environmental stress with ridges.

Patients with depression or anxiety at the time of a diffuse large B-cell lymphoma diagnosis tended to have worse survival, recent research showed.

Lymphoma treatment came with a number of unexpected side effects for me, including a runny nose.

I didn’t expect to be diagnosed with cancer, never mind end up with four diagnoses over the years. Here is what I learned along the way.

Patients with advanced-stage classic Hodgkin lymphoma had a longer progression-free survival rate with Opdivo plus AVD, a chemotherapy regimen, compared with Adcetris plus AVD.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

Growing up, I thought that only “bad boys” used marijuana, but after my cancer diagnosis, my perception slowly changed.

From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.

“Nobody’s going to fight for your life the way you’re going to fight for your life,” Hodgkin’s lymphoma survivor, Paula Ngon, told CURE®.

Breyanzi has reportedly shown promising effects for patients with relapsed or refractory follicular lymphoma and B-cell non-Hodgkin lymphoma.